Citigroup’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Citigroup's CLB Position: Q1 2026 in Review
Citigroup increased its Core Laboratories (CLB) stake by 174% in Q1 2026, buying an estimated $317K and bringing the position to 27,905 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.
Citigroup first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.9M in Q2 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Citigroup held 27,905 shares of Core Laboratories worth $469K as of Q1 2026.
- Citigroup bought 17,709 Core Laboratories shares in Q1 2026, an estimated $317K.
- Core Laboratories made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3590 holding.
- Citigroup first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Core Laboratories position peaked at $15.9M in Q2 2018.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.